Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Trichomonas vaginalis Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG Test

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Trichomonas vaginalis is a prevalent sexually transmitted infection (STI). Diagnosis has historically relied on either microscopic analysis or culture, the latter being the previous gold standard. However, these tests are not readily available for male diagnosis, generally only perform well for symptomatic women, and are not as sensitive as nucleic acid amplification tests (NAATs). Men are largely asymptomatic but carry the organism and transmit to their sexual partners. This multicenter, prospective study evaluated the performance of the cobas T. vaginalis/ Mycoplasma genitalium (TV/MG) assay for detection of T. vaginalis DNA compared with patient infection status (PIS) defined by a combination of commercially available NAATs and culture using urogenital specimens. A total of 2,064 subjects (984 men and 1,080 women, 940 [45.5%] symptomatic, 1,124 [54.5%] asymptomatic) were evaluable. In women, sensitivity ranged from 99.4% (95% confidence interval [CI] 96.8 to 99.9%) using vaginal samples to 94.7% (95% CI 90.2 to 97.2%) in PreservCyt samples. Specificity ranged from 98.9 to 96.8% (95% CI 95.4 to 97.8%). In men, the cobas TV/MG assay was 100% sensitive for the detection of T. vaginalis in both male urine samples and meatal swabs, with specificity of 98.4% in urine samples and 92.5% in meatal swabs. The cobas TV/MG is a suitable diagnostic test for the detection of T. vaginalis, which could support public health efforts toward infection control and complement existing STI programs.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

          Diagnostic accuracy studies are, like other clinical studies, at risk of bias due to shortcomings in design and conduct, and the results of a diagnostic accuracy study may not apply to other patient groups and settings. Readers of study reports need to be informed about study design and conduct, in sufficient detail to judge the trustworthiness and applicability of the study findings. The STARD statement (Standards for Reporting of Diagnostic Accuracy Studies) was developed to improve the completeness and transparency of reports of diagnostic accuracy studies. STARD contains a list of essential items that can be used as a checklist, by authors, reviewers and other readers, to ensure that a report of a diagnostic accuracy study contains the necessary information. STARD was recently updated. All updated STARD materials, including the checklist, are available at http://www.equator-network.org/reporting-guidelines/stard. Here, we present the STARD 2015 explanation and elaboration document. Through commented examples of appropriate reporting, we clarify the rationale for each of the 30 items on the STARD 2015 checklist, and describe what is expected from authors in developing sufficiently informative study reports.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Two-sided confidence intervals for the single proportion: comparison of seven methods.

            Simple interval estimate methods for proportions exhibit poor coverage and can produce evidently inappropriate intervals. Criteria appropriate to the evaluation of various proposed methods include: closeness of the achieved coverage probability to its nominal value; whether intervals are located too close to or too distant from the middle of the scale; expected interval width; avoidance of aberrations such as limits outside [0,1] or zero width intervals; and ease of use, whether by tables, software or formulae. Seven methods for the single proportion are evaluated on 96,000 parameter space points. Intervals based on tail areas and the simpler score methods are recommended for use. In each case, methods are available that aim to align either the minimum or the mean coverage with the nominal 1 -alpha.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues

              Trichomonas vaginalis (TV) is likely the most common non-viral sexually transmitted infection (STI) in the world. It is as an important source of reproductive morbidity, a facilitator of HIV transmission and acquisition, and thus it is an important public health problem. Despite its importance in human reproductive health and HIV transmission, it is not a reportable disease and surveillance is not generally done. This is problematic since most persons infected with TV are asymptomatic. Metronidazole (MTZ) has been the treatment of choice for women for decades, and single dose has been considered the first line of therapy. However, high rates of retest positive are found among TV infected persons after single dose MTZ treatment. This has not been explained by drug resistance since in vitro resistance is only 2–5 %. Treatment failure can range from 7–10 % and even higher among HIV+ women. Treatment efficacy may be influenced by vaginal ecology. The origins of repeat positives need further explanation and better treatment options are needed.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                J Clin Microbiol
                J Clin Microbiol
                JCM
                Journal of Clinical Microbiology
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                0095-1137
                1098-660X
                28 July 2021
                20 September 2021
                October 2021
                20 September 2021
                : 59
                : 10
                : e00264-21
                Affiliations
                [a ] School of Medicine, University of Alabama at Birminghamgrid.265892.2, , Birmingham, Alabama, USA
                [b ] Baylor Scott & White Health, Temple, Texas, USA
                [c ] Laboratory Corporation of America Holdings, Burlington, North Carolina, USA
                [d ] Segal Trials, Inc., Miami Lakes, Florida, USA
                [e ] Indiana University School of Medicine, Indianapolis, Indiana, USA
                [f ] Planned Parenthood of Southern New England, New Haven, Connecticut, USA
                [g ] School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA
                [h ] Brown University, Providence, Rhode Island, USA
                [i ] The University of Mississippi Medical Centergrid.410721.1, , Jackson, Mississippi, USA
                [j ] BioCollections Worldwide, Inc., Miami, Florida, USA
                [k ] Roche Molecular Systems Inc., Pleasanton, California, USA
                [l ] Quest Diagnostics Infectious Disease, San Juan Capistrano, California, USA
                [m ] Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
                Mayo Clinic
                Author notes

                Citation Van Der Pol B, Rao A, Nye MB, Chavoustie S, Ermel A, Kaplan C, Eisenberg D, Chan PA, Mena L, Pacheco S, Waites KB, Xiao L, Krishnamurthy S, Mohan R, Bertuzis R, McGowin CL, Arcenas R, Marlowe EM, Taylor SN. 2021. Trichomonas vaginalis detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG test. J Clin Microbiol 59:e00264-21. https://doi.org/10.1128/JCM.00264-21.

                Author information
                https://orcid.org/0000-0003-3064-8564
                https://orcid.org/0000-0002-8775-765X
                https://orcid.org/0000-0003-0188-4023
                https://orcid.org/0000-0002-7023-5193
                Article
                00264-21
                10.1128/JCM.00264-21
                8451429
                34319805
                70f70e00-7647-4874-b4f1-595faa20b760
                Copyright © 2021 Van Der Pol et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 5 February 2021
                : 11 April 2021
                : 6 July 2021
                Page count
                Figures: 2, Tables: 3, Equations: 0, References: 28, Pages: 9, Words: 5303
                Funding
                Funded by: Roche Molecular Diagnostics;
                Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient :
                Categories
                Parasitology
                clinical-microbiology, Clinical Microbiology
                Custom metadata
                October 2021

                Microbiology & Virology
                naat,trichomonas vaginalis,molecular methods,urogenital
                Microbiology & Virology
                naat, trichomonas vaginalis, molecular methods, urogenital

                Comments

                Comment on this article